Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia

被引：0
|
作者：
Gopisree Peringeth
Suchitra Sundaram
Paul Bogner
Elizabeth Conroy
Pallawi Torka
机构：
[1] Roswell Park Comprehensive Cancer Center,Department of Medicine
[2] Roswell Park Comprehensive Cancer Center,Department of Pathology and Laboratory Medicine
[3] Dermatology,undefined
[4] Buffalo Medical Group,undefined
来源：
Annals of Hematology | 2020年 / 99卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1129 / 1131
页数：2
相关论文
共 50 条
  • [41] An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Salvaris, Ross
    Opat, Stephen
    FUTURE ONCOLOGY, 2020, 17 (04) : 371 - 387
  • [42] Venetoclax ramp-up with concurrent voriconazole in a patient with chronic lymphocytic leukemia
    Krapfl, Aaron
    McLeod, Caleb
    Myers, Rebecca
    Venugopal, Parameswaran
    Seddon, Amanda
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1898 - 1901
  • [43] The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia
    Pamuk, Gulsum Emel
    Turgut, Burhan
    Demir, Muzaffer
    Tezcan, Fatma
    Vural, Ozden
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (08) : 631 - 633
  • [44] Successful use of mepolizumab in a patient with chronic eosinophilic pneumonia
    Jithpratuck, Warit
    Sriaroon, Panida
    Samuel, Vinny O.
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 355 - 355
  • [45] CHRONIC LYMPHOCYTIC LEUKEMIA UNCOVERED BY SUCCESSFUL TREATMENT OF ACUTE MYELOID LEUKEMIA
    WARWICK, R
    GOLDSTONE, AH
    JANOSSY, G
    BRITISH MEDICAL JOURNAL, 1976, 2 (6044): : 1111 - 1112
  • [46] Real-world duration of venetoclax treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Teschemaker, Anna
    Hakre, Shweta
    Tse, Jenny
    Shaikh, Nazneen Fatima
    Gu, Yifan
    Near, Aimee
    LEUKEMIA & LYMPHOMA, 2023, 64 : S62 - S63
  • [47] Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia
    Owen, Carolyn
    Christofides, Anna
    Johnson, Nathalie
    Lawrence, Tatiana
    MacDonald, David
    Ward, Carol
    LEUKEMIA & LYMPHOMA, 2017, 58 (12) : 2777 - 2785
  • [48] Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
    Zielinska, Patrycja
    Markiewicz, Miroslaw
    Dzierzak-Mietla, Monika
    Koclega, Anna
    Helbig, Grzegorz
    Kyrcz-Krzemien, Slawomira
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [49] Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax
    Waldron, Madeline
    Winter, Allison
    Hill, Brian T.
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1255 - 1266
  • [50] Venetoclax as a therapeutic option for the treatment of chronic lymphocytic leukemia: the evidence so far
    Held, Lauren
    Siu, Chloe
    Shadman, Mazyar
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 655 - 665
12345